BioNTech SE (BNTX)
112.82
-3.75
(-3.22%)
USD |
NASDAQ |
Aug 24, 16:00
113.17
+0.35
(+0.31%)
After-Hours: 20:00
BioNTech Net Income (Quarterly) : -954.35M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -954.35M |
| March 31, 2026 | -622.28M |
| December 31, 2025 | -355.00M |
| September 30, 2025 | -33.54M |
| June 30, 2025 | -438.19M |
| March 31, 2025 | -437.61M |
| December 31, 2024 | 276.81M |
| September 30, 2024 | 217.62M |
| June 30, 2024 | -869.63M |
| March 31, 2024 | -341.99M |
| December 31, 2023 | 492.43M |
| September 30, 2023 | 174.71M |
| June 30, 2023 | -207.22M |
| Date | Value |
|---|---|
| March 31, 2023 | 538.83M |
| December 31, 2022 | 2.324B |
| September 30, 2022 | 1.797B |
| June 30, 2022 | 1.779B |
| March 31, 2022 | 4.149B |
| December 31, 2021 | 3.619B |
| September 30, 2021 | 3.785B |
| June 30, 2021 | 3.360B |
| March 31, 2021 | 1.359B |
| December 31, 2020 | 437.43M |
| September 30, 2020 | -245.49M |
| June 30, 2020 | -97.24M |
| March 31, 2020 | -58.81M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Moderna, Inc. | -782.00M |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -7.018M |
| NuCana Plc | -4.134M |
| MediGene AG | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 122.78M |
| Total Expenses (Quarterly) | 1.077B |
| EPS Diluted (Quarterly) | -3.799 |
| Enterprise Value | 12.75B |
| Gross Profit Margin (Quarterly) | -169.3% |
| Profit Margin (Quarterly) | -777.3% |
| Earnings Yield | -6.96% |
| Normalized Earnings Yield | -3.797 |